AbMole Products Use Citations

Obstructive Sleep Apnea Syndrome Exacerbates NASH Progression via Selective Autophagy-Mediated Eepd1 Degradation
【IF: 14.3】Advanced Science. 2024 Jun 28  Retigabine 2HCl purchased from AbMole

Fluorescent Nanoparticles Achieve Efficient Photothermal Conversion and Enhanced Antitumor Efficacy Through Intermolecular Aggregation-Caused Quenching
【IF: 13.9】Aggregate. 2024 Dec 19  IR808 purchased from AbMole

HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells
【IF: 13.7】Cell Death Differ. 2024 Dec 03  DT2216 purchased from AbMole

ZLN005 alleviates PBDE-47 induced impairment of mitochondrial translation and neurotoxicity through PGC-1α/ERRα axis
【IF: 13.6】J Hazard Mater. 2024 Apr 16;471:134331  ZLN005 purchased from AbMole

Room-temperature-stable immunosuppressive nanovesicles for mitigating immunopathology and streamlining cardioprotection post-infarction
【IF: 13.3】Chem Eng J. 2024 Oct 23  4% Paraformaldehyde Fix Solution purchased from AbMole

Frameshift variants in C10orf71 cause dilated cardiomyopathy in human, mouse, and organoid models
【IF: 13.3】J Clin Invest. 2024 Jun 17;134(12):e177172  Omecamtiv mecarbil purchased from AbMole

The novel lnc-HZ12 suppresses autophagy degradation of BBC3 by preventing its interactions with HSPA8 to induce trophoblast cell apoptosis
【IF: 13.3】Autophagy. 2024 Jun 6  Cycloheximide purchased from AbMole

Bioengineering human heavy-chain nanoferritin for glioblastoma multiforme-specific delivery and efficient immunotherapy
【IF: 13.3】Chem Eng J. 2024 Nov 10  Avelumab (MSB0010718C) purchased from AbMole

Leveraging chemotherapy-induced PD-L1 upregulation to potentiate targeted PD-L1 degradation using nanoparticle-based targeting chimeras
【IF: 13.3】Chem Eng J. 2024 Sep 18  Cell Counting Kit-8 purchased from AbMole

A supramolecular assembly strategy for the treatment of rheumatoid arthritis with ultrasound-augmented inflammatory microenvironment reprograming
【IF: 12.8】Biomaterials. 2024 Dec 10;316:123006  CYM-5442 purchased from AbMole

RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer
【IF: 12.8】Exp Mol Med. 2024 Mar 1  Actinomycin D purchased from AbMole

METTL3-mediated pre-miR-665/DLX3 m6A methylation facilitates the committed differentiation of stem cells from apical papilla
【IF: 12.8】Exp Mol Med. 2024 Jun 3  Actinomycin D purchased from AbMole